Related Experiment Video

Updated: Aug 24, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Raf kinase inhibitor protein: a prostate cancer metastasis suppressor gene

Evan T Keller1, Zheng Fu, Kam Yeung

  • 1Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA. etkeller@umich.edu

Cancer Letters
|May 21, 2004
PubMed

Insights

Loss of Raf kinase inhibitor protein (RKIP) is linked to cancer metastasis. Restoring RKIP inhibits metastasis without affecting primary tumor growth, identifying it as a key metastasis suppressor.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Metastasis is a critical factor in cancer mortality.
  • Raf kinase inhibitor protein (RKIP) signaling pathways are implicated in cellular functions.
  • RKIP's role in cancer biology, including apoptosis and signaling modulation, is under investigation.

Purpose of the Study:

  • To investigate the role of RKIP in prostate cancer metastasis.
  • To identify RKIP as a potential metastasis suppressor gene.
  • To explore RKIP as a molecular target for controlling cancer spread.

Main Methods:

  • Gene array screening comparing non-metastatic and metastatic prostate cancer cell lines.
  • Analysis of RKIP expression in prostate cancer tissues and cell lines.
  • Functional studies involving restoration of RKIP expression in metastatic cells.

Main Results:

  • Decreased RKIP expression was observed in metastatic prostate cancer cells and patient metastases.
  • Loss of RKIP correlates with increased metastatic potential.
  • Restoration of RKIP inhibited metastasis in prostate cancer cell lines without impacting primary tumor growth.

Conclusions:

  • RKIP functions as a metastasis suppressor gene in prostate cancer.
  • RKIP's ability to inhibit metastasis suggests its potential as a therapeutic target.
  • RKIP's multifaceted roles in signaling pathways contribute to its function in cancer progression.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...